Literature DB >> 13677423

Global epidemic of type 2 diabetes: implications for developing countries.

Kwame Osei1.   

Abstract

Diabetes has reached epidemic proportions in many populations. Current estimates suggest that the number of persons with diabetes will reach 250 million by 2010 and 300 million by 2025. The majority of these patients will have type 2 diabetes and reside in developing countries. Type 2 diabetes and its associated long-term complications continue to accelerate among patients who reside in developing countries. Apart from microscopic complications, cardiovascular disease, with its attending morbidity and mortality, is on the rise in the developing countries. Current evidence suggests that environmental factors are major determinants of the increasing rates of diabetes. Addressing these environmental factors offers a unique opportunity for preventing diabetes; health programs that aim to encourage physical activity and discourage (or limit) overweight and obesity deserve significant attention. Prevention must be the cornerstone for international health organizations and ministries of health in developing countries as they plan diabetes management programs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13677423

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  12 in total

1.  Insulin analogs for the treatment of diabetes mellitus: therapeutic applications of protein engineering.

Authors:  Daniel F Berenson; Allison R Weiss; Zhu-Li Wan; Michael A Weiss
Journal:  Ann N Y Acad Sci       Date:  2012-03-13       Impact factor: 5.691

2.  Predictors of poor adherence to antidiabetic therapy in patients with type 2 diabetes: a cross-sectional study insight from Ethiopia.

Authors:  Gebre Teklemariam Demoz; Shishay Wahdey; Degena Bahrey; Halefom Kahsay; Gebremariam Woldu; Yirga Legesse Niriayo; Andrew Collier
Journal:  Diabetol Metab Syndr       Date:  2020-07-16       Impact factor: 3.320

Review 3.  Design of non-standard insulin analogs for the treatment of diabetes mellitus.

Authors:  V Pandyarajan; M A Weiss
Journal:  Curr Diab Rep       Date:  2012-12       Impact factor: 4.810

4.  Association of comorbid depression, anxiety, and stress disorders with Type 2 diabetes in Bahrain, a country with a very high prevalence of Type 2 diabetes.

Authors:  W Almawi; H Tamim; N Al-Sayed; M R Arekat; G M Al-Khateeb; A Baqer; H Tutanji; C Kamel
Journal:  J Endocrinol Invest       Date:  2008-11       Impact factor: 4.256

5.  Metformin versus sulphonylureas for new onset atrial fibrillation and stroke in type 2 diabetes mellitus: a population-based study.

Authors:  Jiandong Zhou; Guoming Zhang; Carlin Chang; Oscar Hou In Chou; Sharen Lee; Keith Sai Kit Leung; Wing Tak Wong; Tong Liu; Abraham Ka Chung Wai; Shuk Han Cheng; Qingpeng Zhang; Gary Tse
Journal:  Acta Diabetol       Date:  2022-02-03       Impact factor: 4.280

6.  Assessment of quality of care given to diabetic patients at Jimma University Specialized Hospital diabetes follow-up clinic, Jimma, Ethiopia.

Authors:  Esayas K Gudina; Solomon T Amade; Fessahaye A Tesfamichael; Rana Ram
Journal:  BMC Endocr Disord       Date:  2011-12-20       Impact factor: 2.763

7.  Conformational dynamics of insulin.

Authors:  Qing-Xin Hua; Wenhua Jia; Michael A Weiss
Journal:  Front Endocrinol (Lausanne)       Date:  2011-10-18       Impact factor: 5.555

8.  Recent challenges in insulin delivery systems: a review.

Authors:  M M Al-Tabakha; A I Arida
Journal:  Indian J Pharm Sci       Date:  2008 May-Jun       Impact factor: 0.975

9.  Validity and reliability of accelerometer-based gait assessment in patients with diabetes on challenging surfaces.

Authors:  Eling D de Bruin; Michèle Hubli; Pamela Hofer; Peter Wolf; Kurt Murer; Wiebren Zijlstra
Journal:  J Aging Res       Date:  2012-07-31

10.  Waist circumference independently associates with the risk of insulin resistance and type 2 diabetes in mexican american families.

Authors:  Manju Mamtani; Hemant Kulkarni; Thomas D Dyer; Laura Almasy; Michael C Mahaney; Ravindranath Duggirala; Anthony G Comuzzie; John Blangero; Joanne E Curran
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.